Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06695416 · ClinicalTrials.gov registry record
Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX
A clinical trial of Blood Alcohol Concentration and Drunk Driving, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06695416: Recruiting study of Blood Alcohol Concentration and Drunk Driving, sponsored by Methodist Health System.
NCT06695416 is a study of Blood Alcohol Concentration and Drunk Driving that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06695416, a study of Blood Alcohol Concentration and Drunk Driving, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assault, intimate partner violence, and suicide". In the city of Dallas, violent crimes have decreased by roughly 4% in 2022 compared to 2021. Dallas Police Department (DPD) implemented changes in May 2021 to combat violent crimes.
Conditions Studied
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-04-28 |
| Est. Completion | 2025-04-28 |
What NCT06695416 shows while recruiting
NCT06695416 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Blood Alcohol Concentration appearing as the primary indexed condition, and to 0 interventions.
NCT06695416 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06695416 about?
NCT06695416 is a clinical study titled "Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX". According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assault, intimate partner violence, and suicide". In the city of Dallas, violent crimes have decreased by roughly 4% in 2022 compared to 2021. Dal...
What is the current status of trial NCT06695416?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-04-28. Estimated completion is 2025-04-28.
What conditions does trial NCT06695416 study?
This clinical trial studies the following conditions: Blood Alcohol Concentration, Drunk Driving.
Who is sponsoring clinical trial NCT06695416?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06695416 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI